|Day Low/High||71.46 / 75.14|
|52 Wk Low/High||26.49 / 81.80|
$60 is our Point and Figure target so far.
It might be best to wait for a pullback in shares of the diagnostic and testing company before buying.
Two intriguing names are my choices for the year ahead.
This list is not a buy list but a list of stocks that have been brought to new heights.
Let's see if the two are in alignment.
These 'bearish bets' are showing both technical and quantitative deterioration.
Let's check out the charts and indicators of this medical equipment maker.
As the Fed press conference drones on with nothing new being shared, let's turn our gaze to what we'll be facing after the close -- more earnings! A quick scan says we have roughly 135 reports coming at us in just over one hour's time. In terms of t...
FireEye, Achaogen, Hologic and LGI Homes present attractive values in a challenging market.
I have often found that insider buying in small- and mid-cap stocks can be a huge 'tell'.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
It's a wonder to me how split this market really is.
Stock is set to break out to the upside
Their overseas business has been carrying them.
We know that we are in the era when index managers are ascendant.
Here's a window into what institutional investors may be doing and how to profit from that.
Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.
Lots of energy names facing the potential for lower prices.
Longs should protect their positions and take appropriate action on a close below $80.